Fred Hutchinson Cancer Research Center

Site:	Fred Hutchinson Cancer Research Center
Address:	825 Eastlake Ave E,
City:	Seattle
State:	WA
Zip:	98109
Country:	USA

Phase	Trial	Trial Status	Site Status	Drug	NCT#
3	Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor	Terminated	Closed	Imatinib + Bevacizumab	NCT00324987
2	KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting	Recruiting	Active	KQB198 + Imatinib	NCT07406633
1	Open Label Regorafenib Study to Evaluate Cardiovascular Safety Parameters, Tolerability, and Anti-tumor Activity	Ongoing, but not recruiting	Closed	Regorafenib (BAY 73-4506) + Moxifloxacin	NCT01339104
1	A Dose-finding Study of a Combination of Imatinib and BKM120 in the Treatment of 3rd Line GIST Patients	Completed	Closed	Imatinib + BKM120	NCT01468688
3	(VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST	Active, not recruiting	Active	Avapritinib or Regorafenib	NCT03465722